Sponsor content
21 result(s) found, displaying 1 to 10
- Australian Public Assessment Report (AusPAR)AusPAR: CannabidiolAustralian Public Assessment Report for Cannabidiol
- Australian Public Assessment Report (AusPAR)AusPAR: Beclometasone dipropionate/ formoterol fumarate/ glycopyrronium bromideAustralian Public Assessment Report for Beclometasone dipropionate/ formoterol fumarate/ glycopyrronium bromide
- Prescription medicine decision summaryEpidyolexTGA decision: Epidyolex (cannabidiol) is approved as adjunctive therapy for seizures associated with Dravet and Lennox-Gastaut syndrome
- Prescription medicine registrationEPIDYOLEX (Emerge Health Pty Ltd)Active ingredients: cannabidiol.
- Australian Public Assessment Report (AusPAR)AusPAR: Dinutuximab betaAustralian Public Assessment Report for Dinutuximab beta
- Prescription medicine registrationTRIMBOW (Emerge Health Pty Ltd)Active ingredients: beclometasone dipropionate; formoterol (eformoterol) fumarate dihydrate; glycopyrronium bromide (glycopyrrolate).
- Prescription medicine registrationQARZIBA (Emerge Health Pty Ltd)Active ingredients: dinutuximab beta.
- Prescription medicine registrationFOSTAIR (Emerge Health Pty Ltd)Active ingredients: beclometasone dipropionate; formoterol (eformoterol) fumarate dihydrate.